229029530	229029530	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
11599193	11599193	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2090286	2090286	CD	B-NP	O
|	|	CC	I-NP	O
8/28/2005	8/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ACUTE	ACUTE	NNP	I-NP	I-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2005	3/18/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SPILIAKOS	SPILIAKOS	NN	B-NP	B-protein
,	,	,	O	O
JODY	JODY	NNP	B-NP	O
DOMENIC	DOMENIC	NNP	I-NP	O
MD	MD	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Acute	Acute	NN	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Deglopper	Deglopper	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
CHF	CHF	NN	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
unsuccessful	unsuccessful	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
following	follow	VBG	I-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
oliguria	oliguria	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
seven	seven	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
travelling	travel	VBG	I-VP	O
on	on	IN	B-PP	O
vocation	vocation	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
dosages	dosage	NNS	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
medicines	medicine	NNS	I-NP	O
specifically	specifically	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
reduced	reduce	VBD	B-VP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
Lasix	Lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
480	480	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
his	his	PRP$	B-NP	O
Lotrel	Lotrel	NN	I-NP	O
by	by	IN	B-PP	O
half	half	NN	B-NP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
mg/40	mg/40	NN	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
mg/20	mg/20	NN	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
taking	take	VBG	I-VP	O
Humalog	Humalog	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
45	45	CD	I-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
Humulin	Humulin	NN	B-NP	B-protein
5	5	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
away	away	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
as	as	RB	B-ADJP	O
good	good	JJ	I-ADJP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
ever	ever	RB	I-VP	O
felt	feel	VBN	I-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
longer	long	JJR	B-NP	O
distances	distance	NNS	I-NP	O
and	and	CC	B-PP	O
over	over	IN	B-PP	O
all	all	DT	B-NP	O
felt	feel	VBD	B-VP	O
much	much	RB	B-ADJP	O
stronger	strong	JJR	I-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
that	that	IN	B-SBAR	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
urinating	urinate	VBG	B-VP	O
as	as	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
of	of	IN	B-PP	O
4-5	4-5	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
only	only	RB	I-VP	O
urinate	urinate	VB	I-VP	O
2-3	2-3	CD	B-NP	O
times	time	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
urinate	urinate	VB	I-VP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
on	on	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
put	put	VBD	B-VP	O
out	out	RP	B-PRT	O
merely	merely	RB	B-ADVP	O
a	a	DT	B-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
stream	stream	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
usual	usual	JJ	I-NP	O
strength	strength	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
report	report	VB	I-VP	O
dysuria	dysuria	NN	B-NP	O
or	or	CC	I-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
incomplete	incomplete	JJ	B-NP	O
voiding	voiding	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
usually	usually	RB	B-ADVP	O
fluctuated	fluctuate	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
4-6	4-6	CD	I-NP	O
pounds	pound	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
gained	gain	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
12	12	CD	I-NP	O
pounds	pound	NNS	I-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
oliguria	oliguria	NN	I-NP	O
presented	present	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
are	be	VBP	B-VP	O
swollen	swell	VBN	I-VP	O
more	more	RBR	B-ADVP	O
than	than	IN	B-PP	O
usual	usual	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
or	or	CC	I-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

MEDICAL	MEDICAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
95.8	95.8	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/50	90/50	CD	I-NP	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
male	male	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
normocephalic	normocephalic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
with	with	IN	B-PP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
pupils	pupil	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hearing	hearing	NN	I-NP	O
and	and	CC	I-NP	O
vision	vision	NN	I-NP	O
were	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
JVD	JVD	NN	B-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
PMI	PMI	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

Midsystolic	Midsystolic	JJ	B-NP	O
and	and	CC	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
best	best	RB	B-ADVP	O
heard	hear	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	B-DNA
3	3	CD	I-NP	I-DNA
out	out	IN	B-PP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
scars	scar	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
1-2	1-2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
ankles	ankle	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
warmth	warmth	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
calf	calf	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
labs	lab	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
hyponatremia	hyponatremia	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
130	130	CD	B-NP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.0	3.0	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
9.7	9.7	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
36.0	36.0	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
212	212	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
or	or	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
presentation	presentation	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
low-effective	low-effective	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
volume	volume	NN	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
contributed	contribute	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
aggressively	aggressively	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
furosemide	furosemide	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
renal	renal	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
increased	increase	VBD	B-VP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
261	261	CD	B-NP	O
pounds	pound	NNS	I-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
254	254	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
weight	weight	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
oliguria	oliguria	NN	B-NP	O
was	be	VBD	B-VP	O
249	249	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diurese	diurese	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
per	per	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
before	before	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
them	them	PRP	B-NP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
diurese	diurese	JJ	B-ADJP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
his	his	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
therapy	therapy	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Sperandio	Sperandio	NNP	I-NP	O
experienced	experience	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
pronounced	pronounced	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

During	During	IN	B-PP	O
each	each	DT	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
always	always	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiographic	echocardiographic	JJ	I-NP	O
exam	exam	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
to	to	TO	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
isosorbide	isosorbide	NN	B-NP	O
mononitrate	mononitrate	NN	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
actually	actually	RB	B-ADVP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
240	240	CD	B-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
continuous	continuous	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
statins	statin	NNS	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
magnesium	magnesium	NN	I-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
and	and	CC	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
by	by	IN	B-PP	O
fingersticks	fingerstick	NNS	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADJP	O
self-administering	self-administering	JJ	I-ADJP	O
what	what	WP	B-NP	O
he	he	PRP	B-NP	O
needed	need	VBD	B-VP	O
to	to	TO	B-PP	O
coverage	coverage	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
his	his	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
for	for	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
included	include	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
self-administers	self-administer	VBZ	B-VP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
administers	administer	VBZ	B-VP	O
to	to	TO	B-PP	O
himself	himself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
p.o.	p.o.	FW	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
45	45	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
nitroglycerine	nitroglycerine	NN	B-NP	O
sublinguals	sublingual	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
Lotrel	Lotrel	NN	B-NP	O
5/20	5/20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stoss	Stoss	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-0020467	1-0020467	CD	B-NP	O
VFFocus	VFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
PANOWICZ	PANOWICZ	NN	B-NP	O
,	,	,	O	O
MERVIN	MERVIN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LEMARR	LEMARR	NNP	B-NP	O
,	,	,	O	O
REGGIE	REGGIE	NNP	B-NP	O
RODRIGO	RODRIGO	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2817737	2817737	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/20/05	7/20/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/16/05	7/16/05	CD	B-NP	O

